Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

814.90
+10.671.33%
Number of Gainers:36
Number of Losers:15
Number of Flat:3
PE:- -
High:815.32
Open:804.07
Low:799.33
Close:804.23
Volume:102.76M
Turnover:1.50B
Market Cap:139.42B
Float Cap:85.85B

Loading ...

MEC Forecasts $50 Million-$60 Million in 2026 Datacenter, Critical Power Cross-Selling Revenue

Reuters
·
Yesterday

Weatherford, NCS Multistage Set Aug. 31 Election Deadline Ahead of Anticipated Sept. 1 Merger Close

Reuters
·
Yesterday

Weatherford International - Co and NCS Multistage Set Aug 31, 2026 Election Deadline for Merger Consideration

THOMSON REUTERS
·
Yesterday

Analysts’ Top Industrial Goods Picks: Napco Security Technologies (NSSC), QXO Inc (QXO)

TIPRANKS
·
Yesterday

Top Midday Decliners

MT Newswires Live
·
Yesterday

Alert Incorrectly Tagged to RPC Inc Withdrawn

Reuters
·
Yesterday

RPC Acquires Peracidin® Product Line

THOMSON REUTERS
·
Aug 24

Why Is NAPCO Security Stock Soaring Monday?

Benzinga Earnings
·
Aug 24

Asian Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 24

Enerya Enerji and TGS Dis Ticaret Declare Cash Dividends Effective August 25, 2026

TIPRANKS
·
Aug 24

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

TIPRANKS
·
Aug 24

Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access

MT Newswires Live
·
Aug 24

GOLDWAY EDU Completes Share Placement, Raising Approximately HK$4.4 Million Net

Stock News
·
Aug 24

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Humacyte Says Phase 3 V012 Trial Shows ATEV Extends Catheter-Free Dialysis Time in Women

Reuters
·
Aug 24

Humacyte - Seeks to Add Dialysis Access as Second Approved Indication for Atev

THOMSON REUTERS
·
Aug 24

Humacyte - Supplemental Bla to be Supported by Three Phase 3 Studies of Atev

THOMSON REUTERS
·
Aug 24

Humacyte - to File Supplemental Bla with FDA for Atev in Dialysis Access in November 2026

THOMSON REUTERS
·
Aug 24

Humacyte Confirms Plans for Atev Supplemental Bla Filing for Dialysis Access Following FDA Discussions

THOMSON REUTERS
·
Aug 24

Napco Security Soars After Robust Q4 Results

Reuters
·
Aug 24